FDA Strategy: Improving the Safety of Medical Devices - Naomi Schwartz, VP, Services Medcrypt

Topics:

Regulatory, FDA readiness

Watch

FDA Strategy: Improving the Safety of Medical Devices - Naomi Schwartz, VP, Services Medcrypt

December 12, 2023

This is some text inside of a div block.

Time:

In this interview, Naomi Schwartz, Vice President, Services at MedCrypt discusses the overall concerns with cybersecurity, the RTA policy, and improving the safety of medical devices.

Speakers

Our team of FDA analysts and cybersecurity experts provide robust and actionable cybersecurity roadmaps to ensure you meet FDA requirements. Get the Medcrypt advantage today!

Naomi Schwartz

Sr Director of Cybersecurity Quality and Safety

SBOM & vulnerability management

Data security & privacy

Device monitoring & incident response

FDA

EU MDR (coming soon)

Health Canada (coming soon)

Cryptography design and review

All services

FDA cybersecurity readiness

FDA cybersecurity filing remediation

FDA hold letter response

Threat modeling

Cryptography design and review

FDA Strategy: Improving the Safety of Medical Devices - Naomi Schwartz, VP, Services Medcrypt

Speakers

Naomi Schwartz

More resources

Research, not marketing

FDA, RTA and eSTAR - oh my!